Objective:To identify the strain and to study the in-vitro susceptibilities of Candida species collected from clinical samples of skin and mucosa to Amphotericin B

Ketoconazole

Miconazole

Itraconazole

Fluconazole

5-Flucytosine and Terbinafin. Methods:110 clinical isolates of yeasts were identified by CHROMAGAR and API20C

meanwhile

the susceptibility to six antifungal drugs was examined by microdilution method using Sensititre Yeast One panels. Results:There were 94 C.albicans

6 C.tropicalis

4 C.krusei

4 C.glabrata

and 2 C.parapsilosis among 110 isolates of yeasts.There were 0.91%

1.81%

18.28%

1.81%

5.45%

3.63% and 94.55% of isolates displaying resistance to Amphotericin B

Ketoconazole

Miconazole

Itraconazole

Fluconazole

5-Flucytosine and Terbinafin

respectively.Conclusions:C.albicans is the main infection strain in our hospital

and candida species display different resistance to six antifungal drugs. It is necessary to test strain identification and susceptibility of candida species to guild the rational clinical drug use.